期刊文献+

ROZ与ATRA联合应用对MCF-7细胞诱导作用 被引量:1

Effects of combination of ROZ with ATRA on differentiation of MCF-7 cells
下载PDF
导出
摘要 研究PPARγ激动剂罗格列酮(ROZ)与全反式维甲酸(ATRA)联合应用诱导MCF-7细胞发生分化和凋亡的作用,阐述PPARγ激活后的抗肿瘤作用和机制.采用克隆原形成实验测定两化合物对MCF-7细胞存活率的影响;采用诱导分化实验测定两化合物对MCF-7细胞分化的影响;并进一步应用RT-PCR分析两化合物对MCF-7细胞相关基因表达的影响.集落形成实验显示,两化合物联合应用后,能明显抑制MCF-7细胞的生长.诱导分化实验表明,ROZ在低剂量时促进MCF-7细胞的分化,而随着剂量的增加,分化作用减弱,与ATRA联合应用后,同样在低剂量时促进MCF-7细胞分化,并且出现脂滴的细胞数增加,脂滴增大,在高剂量时,分化作用亦有所减弱.RT-PCR结果表明,在两化合物的作用下,MCF-7细胞中PPARγ的表达升高,并使MCF-7细胞中与凋亡相关基因的表达发生变化.ROZ与ATRA联合应用具有协同作用,激活PPARγ,抑制MCF-7细胞增殖,诱导MCF-7细胞发生分化. To study the effect of differentiation induction and apoptosis induction of combination of PPARy Agonist ROZ with ATRA in MCF -7 cells, and expound the antiOcancer activity and the possible molecular mechanisms of the combination. To detect the differentiation inducing effect by the combination. The colony formation experiment is used to detect the survival rate of MCF -7 cells, the relative gene expression is detected in MCF -7 cells by RT- PCR. Combination of ROZ with ATRA suppressed the colony formation markedly. The ability of differentiation is increased at low dose and decreased at high dose both by ROZ alone and combination of ROZ with ATRA in MCF - 7 cells. The data of RT - PCR showed that combination of ROZ with ATRA could induce the increase in PPARγ mRNA, and cause the changes of ERa,P53, Bcl - 2, bax,E-cad, integrin oL2 mRNA expression. The combination of ROZ and ATRA in MCF -7 cells demonstrated a cooperative effect on growth inhibition, differentiation induction and apoptosis induction.
出处 《哈尔滨商业大学学报(自然科学版)》 CAS 2008年第1期1-6,共6页 Journal of Harbin University of Commerce:Natural Sciences Edition
基金 国家自然科学基金资助项目(30400352)
关键词 ROZ ATRA PPARΓ MCF-7 分化 凋亡 ROZ ATRA PPARγ MCF - 7 differentiation proliferation
  • 相关文献

参考文献1

二级参考文献6

  • 1Gonzalez MA,Pinder SE,Weneyk PM,et al.An immunohisto-chemical examination of the expression of E-cadherin,α and β/γ-catenins,and α2 and β1 integrins in invasive breast cancer[J].J Pathol,1999,187(5):523-9.
  • 2Maruyama K,Ochiai A,Akimoto S,et al.Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer[J].Oncology,2000,59(4):302-9.
  • 3Jones LJ,Veale RB.Redistribution ofbeta-catenin in response to EGF and lithium signalling in human oesophageal squamous carcinoma cell lines[J].Cancer Cell Int,2003,3(1):13.
  • 4Lyakhovitsky A,Barzilai A,Fogel M,et al.Expression ofe-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors[J].Am J Dermatopathol,2004,26(5):372-8.
  • 5Papadavid E,Pignatelli M,Zakynthinos S,et al.Abnormal immunoreactivity of the E-cadherin/catenin (alpha-,beta-,and gamma-)complex in premalignant and malignant non-melanocytic skin tumours[J].J Pathol,2002,196(2):154-62.
  • 6Bayer-Gammer IB,Smoller BR.The expression ofsyndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma[J].J Cutan Pathol,2001,28:83-9.

共引文献1

同被引文献10

  • 1Coelho SM, Vaisman M,Carvalho DP. Tumour re-differentiation ef- fect of retinoic acid:a novel therapeulic approach for advanced thy- roid cancer[J]. Curr Pharm Des,2005,11 ( 19):2525-2531.
  • 2Berthiaume M, Sell H, Lalonde.J, et al .Actions of PPAR gamma agonism on adipose tissue remodeling, insulin sensitivity, and ipemia in absence of glucocorticoids [J]. Am J Physiol Regul Integr Comp Physiol, 2004,287(5):1116-1123.
  • 3Osawa E, Nakajima A, Wada K, et al. Peroxisome proliferator acti- vated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice[J]. Gastroenterology, 2003,124:361-367.
  • 4Fauconnet S, Lascombel I,Chabannes E,et al. Differential regulation of vascvlar endothelial growth factor expression by peroxisome pro- liferator-activated recepters in bladder cancer cells [J].J Boil Chem, 2002,277:23534-23543.
  • 5Kasper HV, Konze E,Dienes HP, et al. COX-2 Expression and Ef- fects of COX-2 Inhibition in Colorectal Carcinomas and their Liver Metastases[J].Anticancer Research, 2010,30(6):2017-2024.
  • 6Horndler C, Gallego R, Gareia-Albeniz X, et al. Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor1 (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximah or panitu- mumab[J]. Cancer Bio Ther, 2011,11 (2):177-183.
  • 7Sorensen NM, Sorensen IV, Wurtz SO, et al. Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment [J]. Stand J Gastroenterol, 2008,43 (7): 774-786.
  • 8Giaginis C, Nikiteas N, Margeli A. et al. Serum tissue inhibitor of metalloproteinases 1 and 2 (TIMP-1 and TIMP-2)levels in cnl- orectal cancer patients:associations with clinicopathological vari- ables and patients survival[J], Int J Binl Markers, 2009,24(4):245- 252.
  • 9饶雪峰,刘伟中,廖传文,彭贵祖,单人锋.MMP-7在肝细胞癌组织中的表达及临床意义[J].世界华人消化杂志,2009,17(28):2903-2907. 被引量:3
  • 10郭仁乐,苗瑞政,徐涛,刘立青,王猛,姜言明.联合应用罗格列酮与维甲酸对HCT-15细胞增殖和凋亡的影响[J].中国现代普通外科进展,2010,13(6):421-425. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部